Herz

, Volume 42, Issue 3, pp 316–324 | Cite as

Temporal trends in transcatheter and surgical aortic valve replacement

An analysis of aortic valve replacements in Germany during 2012–2014
  • L. Gaede
  • W.-K. Kim
  • J. Blumenstein
  • C. Liebetrau
  • O. Dörr
  • H. Nef
  • C. Hamm
  • T. Walther
  • S. Achenbach
  • A. Elsässer
  • H. Möllmann
Original articles

Abstract

This analysis of the data of the obligatory quality assurance programme AQUA shows the perioperative risk as well as the procedural outcome evaluated by the observed versus expected in-hospital mortality ratio (O/E ratio) of 62,872 patients undergoing isolated surgical (sAVR), transcatheter transvascular (TV-), or transapical (TA-) aortic valve replacement (TAVI) from 2012 to 2014 in Germany. The number of TAVI procedures increased from 9,352 in 2012 to 13,278 in 2014, whereas the number of sAVR remained constant (2012: 9,949; 2014: 9,953). Between 2012 and 2014, the number of TAVI implanted in patients with a logistic EuroScore I (logESI) of ≤10 % (2012: 21 %; 2014: 26 %) as well as with a logESI <20 % (2012: 57 %; 2014: 64 %) increased. In-hospital mortality in TAVI patients decreased from 5.2 % (TV: 5.0 %; TA: 7.4 %) in 2012 to 4.2 % (TV: 3.8 %; TA: 5.5 %) in 2014, whereas it was stable for sAVR patients (2012: 2.8 %; 2014: 2.6 %). The O/E ratio of TAVI patients decreased from 0.91 (TV: 0.79; TA: 1.2) to 0.73 (TV: 0.69; TA: 0.89), whereas this ratio remained constant for sAVR patients (2012: 0.92; 2014: 0.93). In summary, estimated surgical risk, in-hospital mortality, as well as the O/E ratio for patients undergoing TAVI declined constantly during the last 3 years.

Keywords

Transcatheter aortic valve replacement Aortic valve stenosis Outcome Mortality Germany 

Ergebnisse nach kathetergestützten und chirurgischen Aortenklappenimplantationen

Eine Analyse der Aortenklappenimplantationen in Deutschland von 2012 bis 2014

Zusammenfassung

Die Analyse aus Daten der verpflichtenden Qualitätssicherung (AQUA) zeigt die perioperativen Risiken sowie das postprozedurale Ergebnis von 62.872 Patienten, die in Deutschland zwischen 2012 und 2014 eine kathetergestützten (TAVI) oder einen isolierten chirurgischen Aortenklappenersatz (AKE) erhielten. Die Anzahl der TAVI stieg von 9352 im Jahr 2012 auf 13.278 im Jahr 2014, während die Zahl der AKE-Operationen konstant blieb (2012: 9949, 2014: 9953). Seit 2012 sind zunehmend Patienten mit niedrigerem Risiko durch TAVI behandelt worden (logistischer EuroScore I (logESI) ≤10 % im Jahr 2012: 21 %; im Jahr 2014: 26 %; logESI <20 % im Jahr 2012: 57 %; im Jahr 2014: 64 %). Die Krankenhaussterblichkeit nach TAVI nahm stetig ab, sie lag 2012 bei 5,2 % (transvaskulär, TV: 5,0 %; transapikal, TA: 7,4 %) und betrug 2014 nur 4,2 % (TV: 3,8 %; TA: 5,5 %), während sie nach AKE konstant blieb (2012: 2,8 %; 2014: 2,6 %). Noch eindrücklicher ist das Verhältnis von beobachteten zu erwarteten Todesfällen (O/E-Verhältnis), das bei TAVI-Patienten drastisch abnahm – von 0,91 im Jahr 2012 (TV: 0,79; TA: 1,2) auf 0,73 im Jahr 2014 (TV: 0,69; TA: 0,89) –, wohingegen es nach AKE konstant blieb (im Jahr 2012: 0,92; im Jahr 2014: 0,93). Zusammenfassend lässt sich sowohl eine Abnahme des geschätzten perioperativen Risikos als auch der Krankenhaussterblichkeit bei TAVI-Patienten feststellen. Von größter Bedeutung ist die sehr vorteilhafte Verbesserung des O/E-Verhältnisses, das 2014 über 20 % niedriger zugunsten der TAVI-Prozedur im Vergleich zur AKE-Operation ausfiel. Diese positive Entwicklung war unabhängig vom zugrunde liegenden Operationsrisiko.

Schlüsselwörter

Kathetergestützte Aortenklappenimplantation Aortenklappenstenose Outcome Mortalität Deutschland 

Notes

Compliance with ethical guidelines

Conflict of interest

L. Gaede, K. Won-Keun, J. Blumenstein, C. Liebetrau, O. Dörr, H. Nef, C. Hamm, T. Walther, S. Achenbach, A. Elsässer and H. Möllmann state that they have no competing interest.

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Eggebrecht H, Mehta RH (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014 : on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11(9):1029–1033. doi: 10.4244/eijy15m09_11 CrossRefGoogle Scholar
  2. 2.
    Lefèvre T, Kappetein AP, Wolner E et al (2011) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148–157. doi: 10.1093/eurheartj/ehq427 CrossRefPubMedGoogle Scholar
  3. 3.
    Smith C, Leon M, Mack M et al (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198CrossRefPubMedGoogle Scholar
  4. 4.
    Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): In-hospital outcome. Eur Heart J 35:1588–1598CrossRefPubMedGoogle Scholar
  5. 5.
    Kapadia SR, Leon MB, Makkar RR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2485–2491CrossRefPubMedGoogle Scholar
  6. 6.
    Mack MJ, Leon MB, Smith CR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484CrossRefPubMedGoogle Scholar
  7. 7.
    Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496CrossRefPubMedGoogle Scholar
  8. 8.
    Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. doi: 10.1056/NEJMoa1514616 Google Scholar
  9. 9.
    Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371:967–968CrossRefPubMedGoogle Scholar
  10. 10.
    Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis – complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559CrossRefPubMedGoogle Scholar
  11. 11.
    AQUA-Institut (2014) Ausfüllhinweise Herzchirurgie (HCH). https://www.sqg.de/downloads/2014/V06/Ausfuellhinweise/Ausfuellhinweise_HCH.htm (Created 28 January 2014)
  12. 12.
  13. 13.
    Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2CrossRefPubMedGoogle Scholar
  14. 14.
    Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977CrossRefPubMedGoogle Scholar
  15. 15.
    Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369CrossRefPubMedGoogle Scholar
  16. 16.
    Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operativ risk stratification models in open-heart surgery. Eur Heart J 27:867–874CrossRefPubMedGoogle Scholar
  17. 17.
    Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897CrossRefPubMedGoogle Scholar
  18. 18.
    Leon M, Smith C, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMedGoogle Scholar
  19. 19.
    Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76CrossRefPubMedGoogle Scholar
  20. 20.
    Popma JJ, Adams DH, Reardon MJ et al (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63:1972–1981CrossRefPubMedGoogle Scholar
  21. 21.
    Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30:74–80CrossRefPubMedGoogle Scholar
  22. 22.
    Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496CrossRefPubMedGoogle Scholar
  23. 23.
    Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751CrossRefGoogle Scholar
  24. 24.
    Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi: 10.1016/j.jacc.2015.03.034 PubMedGoogle Scholar
  25. 25.
    Adams DH, Popma JJ, Reardon MJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798CrossRefPubMedGoogle Scholar
  26. 26.
    Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi: 10.1016/j.jacc.2015.03.014 Google Scholar
  27. 27.
    Rosenhek R, Iung B, Tornos P et al (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828CrossRefPubMedGoogle Scholar
  28. 28.
    Sedaghat A, Sinning J‑M, Vasa-Nicotera M et al (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102:821–829CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2016

Authors and Affiliations

  • L. Gaede
    • 1
    • 3
  • W.-K. Kim
    • 2
    • 4
  • J. Blumenstein
    • 1
  • C. Liebetrau
    • 2
  • O. Dörr
    • 5
  • H. Nef
    • 5
  • C. Hamm
    • 2
    • 5
  • T. Walther
    • 4
  • S. Achenbach
    • 3
  • A. Elsässer
    • 6
  • H. Möllmann
    • 1
  1. 1.Dept. of Internal MedicineSt. Johannes-HospitalDortmundGermany
  2. 2.Dept. of CardiologyKerckhoff Heart and Thorax CenterBad NauheimGermany
  3. 3.Medical Clinic II. Dept. of Cardiology and AngiologyFriedrich Alexander Universität Erlangen-NürnbergErlangenGermany
  4. 4.Dept. of Cardiac SurgeryKerckhoff Heart and Thorax CenterBad NauheimGermany
  5. 5.Medical Clinic I, Dept. of Cardiology and AngiologyUniversity of GiessenGiessenGermany
  6. 6.Dept. of CardiologyKlinikum OldenburgOldenburgGermany

Personalised recommendations